
Sunday, March 31, 2024 4:44:50 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent TLSI News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/10/2025 11:47:21 AM
- TriSalus Reports Q3 2024 Financial Results and Provides Business Update • Business Wire • 11/14/2024 01:00:00 PM
- TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer • Business Wire • 11/11/2024 12:00:00 PM
- TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment • Business Wire • 11/07/2024 12:00:00 PM
- TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call • Business Wire • 10/31/2024 12:00:00 PM
- TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit • Business Wire • 10/14/2024 08:05:00 PM
- TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board • Business Wire • 09/26/2024 11:00:00 AM
- TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System • Business Wire • 09/23/2024 11:00:00 AM
- TriSalus Reports Q2 2024 Financial Results and Business Update • Business Wire • 08/15/2024 12:00:00 PM
- TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call • Business Wire • 08/01/2024 11:00:00 AM
- TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation • Business Wire • 07/01/2024 08:00:00 PM
- TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants • Business Wire • 06/26/2024 09:45:00 PM
- TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 ASCO Annual Meeting • Business Wire • 06/03/2024 11:00:00 AM
- TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants • Business Wire • 05/24/2024 10:05:00 AM
- TriSalus Reports Q1 2024 Financial Results and Business Update • Business Wire • 05/15/2024 12:00:00 PM
- TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors • Business Wire • 05/07/2024 11:00:00 AM
- TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call • Business Wire • 05/06/2024 08:58:00 PM
- TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives • Business Wire • 04/30/2024 08:35:00 PM
- TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update • Business Wire • 04/01/2024 12:00:00 PM
FEATURED NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market • Mar 27, 2025 11:20 AM
FEATURED LaFleur Minerals Announces Memorandum of Understanding with Granada Gold on Milling Assessment for the Granada Gold Project Using the Beacon Gold Mill • Mar 27, 2025 8:40 AM
Nightfood Holdings (NGTF) Issues Shareholder Update on Imminent Strategic Acquisitions and Rapid Expansion in AI-Powered Hospitality Automation • NGTF • Mar 27, 2025 8:30 AM
ConnectM Secures Landmark Home and Building Electrification Project in India, Marking Strategic International Expansion • CNTM • Mar 27, 2025 7:05 AM
$SYNX - Could Silynxcom Be the Next 1000% Israeli Defense Tech Rocketship? (NYSE: SYNX) • SYNX • Mar 26, 2025 12:15 PM
ConnectM Issues Stockholder Letter from CEO & Chairman • CNTM • Mar 26, 2025 12:14 PM